Authors
Latest:
Opioid-Induced Nausea and Vomiting: What the Oncology Nurse Should KnowUp to 40% of patients with cancer who take opioids experience nausea and vomiting.
Latest:
Staying Positive and on Course, Despite Financial HardshipsPlease enjoy this music while your party is reached … "Hello, Mr. Freeman,* this is Venteria Knight. I'm a nurse navigator with Northside Hospital, and we met at the prostate cancer screening last week."
Latest:
Daniela Delbeau on Individuals' Reactions to Cancer TreatmentsDaniela Delbeau, RN, clinical research nurse coordinator at the Perlmutter Cancer Center at NYU Langone Medical Center, discusses how individuals react differently to treatment.
Latest:
Complementary Medicine May Improve Symptoms, But Disparities in Access RemainAs I looked at Ms C, I was struck by the pensive but engaged smile she always sent my way. The same look continued as her daughter elaborated on her mother's condition.
Latest:
Jean Sellers on How to Be a Successful Oncology Nurse NavigatorJean Sellers, RN, MSN, administrative clinical director, UNC Lineberger Comprehensive Cancer Center, discusses how to be a successful oncology nurse navigator.
Latest:
Patient Advisors and Navigators Join Forces to Improve Cancer CareCancer centers throughout the country are faced with an increased demand for cancer care and a shrinking oncology workforce.1 As a result, institutions are struggling to find innovative ways to deliver patient-centered quality care in a cost-effective manner.
Latest:
Meditation Made EasyOncology nurses are in a prime position to introduce meditation to their patients with cancer.
Latest:
Barry Berger Discusses CologuardBarry Berger, MD, Exact Sciences Corporation, discusses Cologuard, an at-home screening for colorectal cancer.
Latest:
Perioperative Breast MRI Does Not Lower Recurrence Risk for Early-Stage PatientsPatients with ductal carcinoma in situ (DCIS) who received an MRI added to mammography before or immediately after receiving a lumpectomy did not experience an improvement in the rate of disease recurrence
Latest:
LUNGevity Takes Step Forward in Clinical Trial Eligibility Reform for Lung Cancer PatientsKey recommendations from LUNGevity's Expanded Eligibility working group were published in the Journal of Thoracic Oncology.
Latest:
Heart Health and Cancer SurvivorsThe American Cancer Society estimates that almost 14.5 million cancer survivors are alive in the United States today. By 2024, the number of survivors will grow to almost 19 million.
Latest:
Cilta-Cel Approved By FDA for Pretreated R/R Multiple MyelomaCilta-cel (ciltacabtagene autoleucel; Carvykti) was approved by the FDA to treat patients with relapsed or refractory multiple myeloma who have previously received at least one line of therapy.
Latest:
There Are 'Tremendous Reasons to Be Hopeful' in MyelomaMyeloma therapies continue to improve, and maybe one day there will be a cure, says one expert.
Latest:
Can We Predict Osimertinib Resistance?There are certain indicators for patients with lung cancer who may progress on osimertinib.
Latest:
Safety of Monoclonal Antibodies in MyelomaKeith Stewart, MB, ChB from Mayo Clinic in Scottsdale, discusses the use of monoclonal antibodies for treatment in multiple myeloma.
Latest:
Fertility Preservation in Breast Cancer SurvivorsAn increasing focus in oncology care is on survivorship and quality-of-life issues that arise once patients are living beyond treatment. For female breast cancer patients, important survivorship issues include sexual and reproductive health.
Latest:
Building Patient-Nurse Trust Is CrucialWhen it comes to patient-nurse relationships in cancer care, "You've got to be there for them," says Jill Schwartz Gomez, RN, CCRP.
Latest:
Diagnosing and Treating Patients with Neuroendocrine Tumors and Carcinoid SyndromeNeuroendocrine tumors (NETs) are rare and often misdiagnosed. These tips can help with the diagnosing and treatment of patients with NETs, and carcinoid syndrome.
Latest:
CURE® Magazine Names Margaret Campbell, BSN, RN, as 2022 Extraordinary Healer®At the 47th Annual ONS Congress, CURE® Media group honored oncology nurses at their 2022 Extraordinary Healer® Award ceremony.
Latest:
Jonathan Schoenfeld on Collaboration for Combination TherapyDr. Jonathan Schoenfeld discusses the need for collaboration among teams when a patient is receiving a combination of immunotherapy and radiation treatment.
Latest:
Nick Dionne-Odom on Potential Explanations for Survival Rates in Patients with CaregiversNick Dionne-Odom, PhD, University of Alabama at Birmingham School of Nursing, discusses potential explanations for decreased survival rates of patients with family caregivers.
Latest:
Data Breakdowns May Uncover More Cancer DisparitiesWhen researchers break ethnic groups down into more specific groups and nationalities, more disparities often become apparent. However, there is a number of reasons why this may not be done, explained Chastity Washington, MPH, CHES.
Latest:
Erin McMenamin on Head and Neck Cancer TreatmentsErin McMenamin, MSN, Radiation Oncology, Hospital of the University of Pennsylvania, discusses treatments for HPV-positive head and neck cancer, which tends to have a better prognosis than HPV-negative head and neck cancers.
Latest:
Tara Sanft on Managing Fear of Recurrence for Patients with Breast CancerTara Sanft discusses how nurses can help support a patient with breast cancer who fears recurrence.
Latest:
Preparing Nurses for Cancer Survivor Care-a Growing NeedWhile oncology nurses have undoubtedly led quality cancer care and patient education initiatives, the current and projected growth of cancer survivors in the United States demands increased attention to developing oncology nurses in the educator role.
Latest:
What's New in the Updated Chemotherapy Administration Safety Standards?Recent recent update to ASCO/ONS standards for chemotherapy administration safety include considerations for a safe healthcare environment, treatment planning, patient education, and consent.
Latest:
The Role of Case Management: Improving Outcomes and Addressing Health Disparities in Cancer CareIn order to meet the multifaceted needs of cancer patients, the role of case management in cancer care has recently grown.
Latest:
Scott Santarella Discusses Exciting Updates in the Field of Lung CancerScott Santarella, president, CEO, Bonnie J. Addario Lung Cancer Foundation, discusses some exciting updates in the field of lung cancer.
Latest:
Toxicities Associated with Ribociclib From MONALEESA-3 TrialOverall survival results from the MONALESSA-3 phase III trial showed positive results for patients with advanced breast cancer, but toxicities related to the use of ribociclib still need to be addressed.
